We will get partnered on Nadolol inhaled. I don't think there is a real possibility that someone somewhere won't stump up $200m (whatever) for some action . The question is when and how much. As for when - I expect very soon. Like in the next month or before the FDA meeting in Dec/jan.
I don't care as much about Zafrilukast or CPN1o right now they're just "bonus" .
We also have time to get the partner signed up now with the rebate.
Buy now or buy on the partnering news?!
It wouldn't surprise me if mgt were not choosing among several bids for partnering right now. The safety profile of Nadolol is so good it makes it easy for a large pharma to throw $100m ++ at it
IVX Price at posting:
1.5¢ Sentiment: Buy Disclosure: Not Held
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)